Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Leukemia|June 21, 2020
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapyMaxi Wass, Stefanie Göllner, Birgit Besenbeck, et al.Clinical Epigenetics|December 12, 2019
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemiaCornelis M van Tilburg, Till Milde, Ruth Witt, et al.Cardiovascular Research|May 24, 2021
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategyFelix Wiedmann, Christoph Beyersdorf, Xiao Bo Zhou, et al.Thrombosis and Haemostasis|December 31, 2024
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF TrialEleni Korompoki, Peter Heuschmann, Kirsten H Harvey, et al.Neuro-Oncology|July 26, 2022
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma modelsRomain Sigaud, Lisa Rösch, Charlotte Gatzweiler, et al.Cell|August 21, 2020
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor ProgressionAhmed Sadik, Luis F Somarribas Patterson, Selcen Öztürk, et al.Lancet (London, England)|March 1, 2025
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trialRoland Veltkamp, Eleni Korompoki, Kirsten H Harvey, et al.Pageof 4